2-190510530-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142645.2(NEMP2):c.961G>A(p.Glu321Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000258 in 1,551,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001142645.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEMP2 | NM_001142645.2 | c.961G>A | p.Glu321Lys | missense_variant | 8/9 | ENST00000409150.8 | NP_001136117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEMP2 | ENST00000409150.8 | c.961G>A | p.Glu321Lys | missense_variant | 8/9 | 2 | NM_001142645.2 | ENSP00000386292.3 | ||
NEMP2 | ENST00000414176.5 | n.*222G>A | non_coding_transcript_exon_variant | 7/7 | 2 | ENSP00000404283.1 | ||||
NEMP2 | ENST00000414176.5 | n.*222G>A | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000404283.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000190 AC: 3AN: 157736Hom.: 0 AF XY: 0.0000360 AC XY: 3AN XY: 83344
GnomAD4 exome AF: 0.00000214 AC: 3AN: 1399660Hom.: 0 Cov.: 31 AF XY: 0.00000290 AC XY: 2AN XY: 690340
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at